HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 1,885-1,896 of 4,505
Drug study icon
CompletedEUCTR 2008-000479-11

A randomised, double-blind, parallel-group, active-controlled, flexible dose study exploring the efficacy and safety of 12 weeks treatment with Lu 31-130 in patients with schizophrenia

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic
SchizophreniaHistorical research record
Countries
France, Czechia, Spain
Sponsor
H. Lundbeck A/S
Drug study icon
CompletedEUCTR 2008-001441-26

A randomised, double-blind, parallel-group, fixed dose study exploring the efficacy and safety of Lu AE58054 as augmentation therapy to risperidone in patients with schizophrenia.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
SchizophreniaHistorical research record
Countries
France, Belgium, Germany, + 2 others
Sponsor
H. Lundbeck A/S
Drug study icon
CompletedEUCTR 2005-001845-40

A Randomized, Crossover Study to Evaluate the Overall Safety and Tolerability of Paliperidone Palmitate Injected in the Deltoid or Gluteus Muscle in Subjects With Schizophrenia

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic
SchizophreniaHistorical research record
Countries
Czechia, Germany, Slovakia
Sponsor
Janssen-Cilag International N.V.
Drug study icon
CompletedEUCTR 2012-000418-13

A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Parallel-group Study of the Safety and Efficacy of ABT-126 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In United Kingdom
SchizophreniaHistorical research record
Countries
United Kingdom
Sponsor
AbbVie Deutschland GmbH & Co. KG

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.